Riskpilot← Back to searchSign inGet full accessZyneyro ApS
APSActiveCVR 42057428Ole Maaløes Vej 3Manufacture of pharmaceutical preparations · NACE 2120Est. 202110 employees
Revenue 2025
DKK -4,6M
-209% vs 2024
EBITDA margin
202.8%
-1398% vs 2024
Equity ratio
78.7%
Financial strength
Net profit 2025
DKK -7,5M
-1221% vs 2024
| Revenue | DKK -4,6M | -209% |
| EBITDA | DKK -9,2M | -1398% |
| Net profit | DKK -7,5M | -1221% |
| Total assets | DKK 5,3M | +272% |
| Equity | DKK 4,1M | +576% |
| Employees | 10 | — |
Legal name
Zyneyro ApS
CVR number
42057428
Legal form
Anpartsselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
26. januar 2021
Share capital
DKK 49.123
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af formanden for bestyrelsen i forening med en direktør.
Company purpose
Selskabets formål er forskning og udvikling af lægemidler, samt dermed beslægtet virksomhed
Address
Ole Maaløes Vej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -27 | -27 | 1.030 | 4.169 | -4.551 |
| Staff expenses | -0 | -0 | -972 | -3.458 | -4.676 |
| EBITDA | -27 | -27 | 58 | 711 | -9.227 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -28 |
| EBIT | -27 | -27 | 58 | 711 | -9.255 |
| Net financials | -2 | -1 | -92 | -2 | -18 |
| Profit before tax | -29 | -28 | -35 | 709 | -9.273 |
| Tax | -0 | -0 | -0 | 43 | -1.806 |
| Net profit | -29 | -28 | -35 | 666 | -7.466 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 464 | 857 | 540 | 1.417 | 5.269 |
| Equity | 11 | -18 | -52 | 614 | 4.147 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 453 | 875 | 592 | 803 | 1.122 |
| Total debt | 453 | 875 | 592 | 803 | 1.122 |
EBITDA margin
-922700800.0%
This company
15.8%
Market median
-5839878581% vs market
20212025
Equity ratio
78.7%
This company
38.2%
Market median
+106% vs market
20212025
Return on equity
-180.0%
This company
18.4%
Market median
-1078% vs market
20212025
Net profit margin
-746644600.0%
This company
8.1%
Market median
-9217834668% vs market
20212025
Asset turnover
-0.86×
This company
1.12×
Market median
-177% vs market
20212025
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-26 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 2024 | — | — |
PH Management | Management | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
UGether ApS | Company | 20.0% | 20.0% | 2025 |
KLMBio ApS | Company | 20.0% | 20.0% | 2025 |
IFO ApS | Company | 20.0% | 20.0% | 2025 |
Marigold Innovation ApS | Company | 20.0% | 20.0% | 2025 |
Marigold Maturation Fund K/S | Company | 15.0% | 15.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MIJJB Holding ApS
Zyneyro ApS Board members of Zyneyro ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Søren Klysner | Management | 0 companies |
| Peter Horn Møller | Management | 0 companies |
| Ulrik Gether | Board of Directors | 0 companies |
| Jacob Ørndrup | Chairman | 0 companies |
| Kenneth Lindegaard Madsen | Board of Directors | 0 companies |
| Andreas Toft Sørensen | Board of Directors | 0 companies |
| Erik Vinther | Board of Directors | 0 companies |